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Abstract
Background: Comorbidity (COM) is an important issue in aging. Cardiovascular disease (CVD) and osteoarthritis separately and together 
may modify the trajectories of functional decline. This analysis examines whether specific and unrelated COMs influence functional change 
differently and vary by gender.
Methods: A cohort study of 1,789 (aged 60 years and older) Mexican Americans was followed annually for up to 10 years. We created 
four groups of COM (CVD alone, lower body osteoarthritis alone [OA], neither, or both). We employed mixed effects Poisson models with 
Instrumental Activities of Daily Living (IADL) as the outcome. We tested whether the association between COM and decline in functional 
status differed by gender.
Results: IADL impairments in those with CVD, OA, or both were significantly higher at baseline and increased more rapidly over time 
compared to those with neither condition. Compared to women with no COM, the number of IADL impairments in women with CVD alone 
were 1.36 times greater, with OA were 1.35 times greater, and both conditions were 1.26 times greater. Compared to men with no COM, IADL 
impairments in men with CVD alone were 1.15 times greater, OA alone were 1.12 times greater, and both were 1.26 times greater.
Conclusions: Over time, the influence of COM on functional decline differs by specific combinations of COM and by gender. Aggregate COM 
scales obscure the biological and temporal heterogeneity in the effects of COM. Time-dependent-specific COMs better assess the development 
of impairment. Women experience a higher burden of functional impairment due to COM than men.
Keywords: Epidemiology—Cardiovascular—Functional performance—Arthritis—Minority aging
As populations and people age, chronic diseases and conditions 
accelerate in number and severity more rapidly over time. A number 
of reports of this process have suggested that women decline in func-
tion more rapidly than men (1,2). Gill and coworkers (3) reported 
that women progress more rapidly than men to severe impairment. 
Analyses from the Leiden 85-plus study also found important gen-
der differences in progression to disability (4). Gender differences 
in functional impairment may vary by type of task, for example, 
women may decline more rapidly than men in activities requiring 
physical effort. As well, the influence of specific comorbid conditions 
on functional ability is likely to vary by gender (5). Grunau and 
coworkers (6) have suggested that disease-specific models perform 
better than a summary score when evaluating prognosis for a specific 
outcome.
The most common methodological approaches to measuring 
comorbidities (COMs) use scales that sum the number of COMs 
(7). These measures are often weighted by prognostic severity of the 
condition based on a prediction of death or other clearly defined 
outcome such as institutionalization. This approach to quantifying 
COM yields a predictable result, namely, that COM increases risk of 
death, institutionalization, and impairment. Performance of several 
different measures of aggregated COM indices with respect to tim-
ing of COM have been examined by Tang and coworkers (8). That 
work found that a summative index, the Charlson scale, performed 
better when measured at baseline, whereas a similar scale performed 
better when assessed closer to outcomes of interest.
Additive approaches such as these may include biologically 
disparate conditions that influence functional decline by different 
pathways or in different directions. Two or more conditions may 
be associated because they have a common antecedent, but are 
not necessarily biologically related. An example of this is the influ-
ence of obesity on osteoarthritis and hypertension/cardiovascular 
disease (CVD). The relative joint timing of multiple COMs is also 
important. Very few studies have traced the trajectory of concur-
rent change in COMs or the influence of such changes on functional 
decline. Wang and coworkers (9) has demonstrated that the use of 
time-dependent COMs is a more effective model for looking at the 
relationship between COMs and mortality. The use of time-depend-
ent accumulation of COMs more accurately reflects the changing 
nature of the exposure over time. Time-dependent covariates are 
allowed to change over time. Time-dependent changes in multiple 
COMs are likely to influence the trajectory of change in functional 
status. The focus of this article is on gender differences in change 
over time in Instrumental Activities of Daily Living (IADL) as pre-
dicted by two time-dependent major COMs—lower body osteoar-
thritis alone (OA) and CVD.
Study Design and Methods
The Sacramento Area Latino Study on Aging (SALSA) is a pop-
ulation-based longitudinal study of older Mexican Americans 
(n = 1,789) living in the Sacramento Valley area of California who 
were 60–101 years old at baseline in 1998–1999 (10). We designed 
SALSA to examine the effects of sociocultural, metabolic, and car-
diovascular risk factors on dementia incidence and cognitive decline 
in this ethnic group. Participants were interviewed and underwent 
clinical examinations in their homes every 12–15 months to 2008 
for up to seven examinations. The study also interviewed partici-
pants by telephone biannually to update medication use and health 
status. Study questionnaires were available in Spanish and English. 
Interviews were conducted in the language that participants pre-
ferred. A detailed description of study procedures has been published 
previously (10). The Institutional Review Boards of the University of 
California San Francisco and Davis and the University of Michigan 
approved the study.
Measurement of Covariates
Comorbidity
CVD and lower body osteoarthritis were selected for this analy-
sis because they are highly prevalent in older populations and fre-
quently co-occur. Also, biological pathways for OA and CVD may 
overlap (11) due to antecedent risk factors in common. Lower body 
OA (as opposed to total OA) was also chosen for its’ significant 
effect on mobility (5).
CVD included nine categories (myocardial infarction, angina 
pectoralis, congestive heart failure, intermittent claudication, stroke, 
atrial fibrillation, deep vein thrombosis, heart catheterization). These 
measures derived from self-report of a doctor’s diagnosis during the 
home visit interviews. Lower body OA was defined by self-report 
from an annual questionnaire. Participant was asked if a physician 
had told them they had arthritis in the hands, shoulder, hips, knees, 
and back. Positive responses to hips, knees, and back were coded as 
lower body.
We constructed a four-category, time-varying COM variable 
based on a subject’s OA and cardiovascular status at each visit. The 
categories were as follows: no COM, lower body OA only, CVD 
only, and both. For example, an individual could have only CVD 
at one visit and acquire lower body OA at the next. In such circum-
stances, he/she would be “CVD only” at visit one and “Both” at visit 
2. We did not allow for “backward” transitions from disease state 
to normal.
Covariates
Other covariates included age in years, nativity (Mexico or other 
country in Latin America vs United States), body mass index, waist 
circumference in inches, physical activity, education in years, and the 
presence or absence of health insurance. Additionally, we included 
diabetes (based on a doctor’s report of diabetes, use of diabetes med-
ication, or fasting glucose > 125), hypertension (based on a doctor’s 
report of hypertension, use of any hypertension medication, or meas-
ured systolic blood pressure ≥ 140, or diastolic blood pressure ≥ 90). 
Others included any alcohol consumption, an acculturation score, 
and cognitive function measured by the Modified Mini-Mental State 
Exam. Physical activity was composed of a summary score for 17 
items with a range of 0–51 (12). Walking pace was based on a ques-
tion about the pace of walking outside (13). The Modified Mini-
Mental State Exam is a global cognitive test ranging from 0 to 100 
(14). A pain score was composed of eight questions regarding the 
presence or absence of pain in a musculoskeletal location (hands, 
feet, knees, hips, neck, back, shoulder, or other) for at least 6 months.
Outcome for Functional Status
IADL were measured at baseline and at each follow-up visit by self-
report of the level of difficulty for a specific activity (15). IADL was 
the primary outcome in this analysis because it is widely used in 
studies of aging, impairment on IADL represents significant effects 
on quality of life, and it is predictive of major outcomes such as 
death. The participant was asked to rate the difficulty (none, some, a 
lot, cannot do without help, or equipment) of specific tasks. Fifteen 
IADL items summed to form a scale that ranged from 0 to 45 (low 
impairment to high; Supplementary Table 1).
Statistical Analysis
We assessed the association of changing patterns of COM (CVD 
and OA) with changes in IADL using mixed effects Poisson regres-
sion analysis. The models included time-varying COM status, time, 
and other covariates as predictors, as well as random intercepts to 
accommodate the repeated measures of IADL for each subject. The 
models also include interactions of time, COM group, and gender 
to allow for assessment in differences in IADL time trends by COM 
and gender. We assessed the statistical significance of the interactions 
using likelihood ratio tests.
We used indicator variables for the COM groups (none, CVD 
only, OA only, both). The COM group “None” was the reference. 
We tested whether there were gender differences in IADL change 
over time by including two-way interaction term (gender × time). 
We tested whether the association between each COM and IADL 
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varied over time with three two-way interactions (COM × time). We 
added a three-way interaction model (gender × COM × time) to test 
whether the association between COM and IADL change differed 
by gender. This result was not statistically significant (likelihood 
ratio = 4, df = 3, p = .26). We stratified analyses on gender.
To test the notion that CVD and OA are biologically related, 
in proportional hazards models, we examined the age- and gender-
adjusted associations between baseline or time-dependent CVD and 
incident OA, and baseline or time-dependent OA and incident CVD. 
All analyses were performed using SAS version 9.4.
Results
Table 1 compares baseline covariates in relation to the four-category 
COM variable by gender.
Among men, age, body mass index, waist circumference, accul-
turation, physical activity score, and nativity did not differ across 
the COM groups. Lower education was associated with OA and 
with OA and CVD. Although more than 90% of the participants 
overall had health insurance, health insurance coverage was lower 
among men with neither condition and highest among men with 
both COM. Type II diabetes was more common in men with CVD 
and in men with both conditions. Hypertension was highest among 
men with CVD or with both conditions and lowest among men 
with neither condition or only with OA. Slow walking pace was 
more common in those with both COM compared to those with 
neither. At baseline, IADL 2+ limitations were highest among those 
with both conditions and lowest among those with neither condi-
tion. A baseline Modified Mini-Mental State Exam score <80 was 
lowest among those with both conditions and highest among those 
with only CVD.
Among women, those with both conditions were older and had 
higher body mass index and waist circumference. Mean education, 
acculturation scores, and physical activity were lowest. Mean pain 
scores and percent with health insurance coverage, diabetes, and 
hypertension were all highest among those with both conditions. 
Alcohol consumption was lowest among those with both OA and 
CVD and highest among those with neither condition. Slow walking 
pace was highest among women with both conditions. Both IADL 
with two or more limitations and baseline Modified Mini-Mental 
State Exam score <80 were highest among those with both condi-
tions. Nativity was unrelated to COM. In sum for both men and 
women, those with both COM were less healthy, less educated, 
more likely to be obese, less physically active, and less likely to drink 
alcohol.
Figure 1 shows the composition of the four COM groups over 
time by gender. Among men, the prevalence of those with no COM 
declines from about 50% at baseline to 20% in year 6. The preva-
lence of those with only OA increases slightly from 15.7% to 20%; 
the prevalence of those with only CVD changes from about 24% 
to about 26%; and the prevalence of those with both conditions 
increases from nearly 10% to 32%. Among women, a similar pat-
tern prevails. Notably, the co-occurrence of CVD and OA is higher at 
baseline in women (18.2%) than in men (9.9%) and increases more 
rapidly over time in women compared to men. At the last follow-up, 
32% of men and 43% of women had both conditions.
Figure 2 and Table 2 show results for time-dependent IADL mod-
eled using mixed effects Poisson models with random intercepts. As 
shown in model 1, interactions between time and the time-depend-
ent COM groups are significant for both men and women such that 
those with OA, CVD, or both conditions develop more functional 
impairment over time compared to those with neither condition. 
As noted earlier, because the three-way interaction between COM 
× gender × time was not significant, the models in Table 2 are gender 
stratified.
Model 1
For both men and women, there are statistically significant interac-
tions between each of the time-dependent COMs and time. Among 
men with OA, CVD, or both conditions, functional impairment 
accelerates more rapidly than among those with neither condition 
(IADL: CVD only = 1.15 greater impairment, OA only 1.12 more 
impairment, both CVD and OA = 1.26 more impairment). Among 
women with OA, CVD, or both conditions, functional impairment 
accelerates more rapidly over time than among those with neither 
condition (IADL count: CVD only  =  1.36 more impairment, OA 
only  =  1.35 more impairment, both CVD and OA  =  1.26 more 
impairment).
Model 2: Adjustment for Covariates
To the models, we added adjustment for covariates identified in bivari-
ate analyses. The results for men remain unchanged from model 1 by 
this addition of covariates. The results for women from model 1 are 
largely unchanged (compared to none, CVD only = 1.32 more impair-
ment, OA = 1.34 more impairment, both = 1.26 more impairment). 
The interaction between time and OA for women is no longer signifi-
cant. Figure 2 illustrates these gender-specific trajectories with specific 
covariate values set at the median or most prevalent condition as noted.
In separate gender-specific and age-adjusted proportional haz-
ards models, baseline CVD was associated with incident OA (men: 
hazard ratio [HR] = 1.50, p = .006; women: HR = 1.37, p = .02). As 
well, time-dependent CVD was associated with incident OA (men: 
HR = 1.50, p = .0004; women: HR = 1.55, p = .0005).
In men, we found that neither baseline nor time-dependent OA 
was associated with incident CVD (HR = 0.96, p = .82; HR = 0.90, 
p = .48). However, in women, both baseline and time-dependent OA 
were associated with CVD incidence (HR baseline = 1.33, p =  .04 
and time-dependent HR = 1.39, p = .03). In men, adjustment of these 
models for physical activity and pain score had no influence on the 
association. In women, these adjustments attenuated the association 
(HR = 1.14, p = .42).
In the scientific literature in general, potential biological/behavio-
ral links between CVD and OA have been identified (11) as physical 
activity, obesity, diabetes, and the use of  nonsteroidal anti-inflam-
matory drugs (NSAIDs). Adjustment for these risk factors (except 
NSAID use) had only minor effects on the associations of COM with 
change over time in IADL (Table 2).
Discussion
Our findings suggest that patterns of associations between these 
two COMs and functional decline vary by gender and COM group. 
Compared to men, women were more impaired at baseline and 
become impaired over time more rapidly, specifically in relation to 
CVD and combined CVD and OA but not for OA alone. The task-
specific patterns of baseline impairment suggest that women were 
more impaired than men in tasks requiring physical effort but not in 
complex tasks such as writing or managing money. The joint pres-
ence of CVD and OA influences function in physical tasks more in 
men than in women. Only CVD or the combination of CVD and OA 
influenced complex tasks over time in women.
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Grunau and coworkers (6) has suggested that disease-specific 
models perform better than a summary score when evaluating prog-
nosis for a specific outcome. The intent of our analysis was to test 
whether the burden of COM on functional decline varies by gender 
over time, using COMs that are likely to affect physical functioning 
independently and in combination. Few studies of functional include 
time-dependent COMs or differences in joint effects (9). Our analy-
sis allows us to disentangle the contributing roles of two commonly 
occurring COMs, CVD and lower body osteoarthritis, on the pro-
gression of functional impairments among older adults.
Other work (11) has suggested that baseline OA is associ-
ated with an increased risk of CVD. We found the opposite that 
CVD was a modest predictor of OA. As suggested by Rahman 
and coworkers (11), the association between OA and CVD may 
be explained by antecedent risk factors such as physical activity, 
obesity, type 2 diabetes, and the use of NSAIDs. In this analysis, 
we have adjusted for all of these risk factors except NSAIDs (due 
to lack of data).
This cohort was entirely Hispanic (95% Mexican ancestry). Few 
other studies have examined the constellation of COM and functional 
change in such a population. Work by Caskie and coworkers (16) 
based on the Hispanic Established Populations for Epidemiologic 
Study of the Elderly (EPESE) study has reported significant increases 
in IADL impairment over a 7-year period in older Hispanics, espe-
cially associated with hypertension. Also in the Hispanic EPESE 
data (17) suggested that IADLs limitations increased over 7 years 
from 2.1 to 4.0 average limitations, or approximately double from 
baseline. Similarly, Jones (18) reported that the number of COMs at 
baseline accelerated IADL impairment. The SALSA population dif-
fers from non-Hispanic White populations in important ways that 
might adversely affect the disablement process. Our participants had 
lower education (average 9 years), were more obese, more diabetic, 
and hypertensive than non-Hispanic White samples. Over 50% of 
the participants were born in Mexico.
The study has some limitations that are important to note: 
Both COMs were based on self-reports of a physician diagnosis. 
Figure 1. Prevalence of four comorbidity groups over time by gender.
Figure 2. Association between time-dependent comorbidities and Instrumental Activities of Daily Living (IADL) counts over time by gender from a mixed effects 
Poisson model with random intercepts.
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This may have resulted in under reporting of less severe conditions. 
As well, we lack radiographic assessments of OA or clinical assess-
ments of impairment that might contribute to functional impair-
ment. However, pain scores were higher and physical activity lower 
in those reporting osteoarthritis with or without CVD (Table  1). 
This confers face validity on the associations with functional 
impairment.
The general concept in this article was to evaluate the joint and 
separate occurrences of COM and their influence of trajectories of 
functional status. We selected two COMs that are common in older 
people, differ by gender, and represent relatively distinct diagnoses. 
Type 2 diabetes is a common health problem in Mexican American 
populations but is more closely associated with CVD than OA and 
did not meet this criteria.
These results support the notion that women experience higher 
burdens of both COM and functional decline than do men. At 
the end of follow-up, women with CVD had twice the IADL 
impairment as men with CVD. Women with both conditions had 
nearly three times the impairment of men with both conditions. 
The reasons for these substantial differences are not clear but have 
important implications for health care of older women. Women 
are often primary caregivers for spouses and elderly parents. If 
they suffer impairment disproportionately, the burden of caring 
for others may add to their functional decline. There has been a 
lack of attention to what the combined effects of specific chronic 
diseases (in this case OA and CVD) might be on functional out-
comes. This provides evidence for the concept that specific and 
unrelated COMs influence functional change and that this varies 
by gender.
Supplementary Material
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Table 2. Association Between Comorbidity and Categories of Impairment in IADL, by Gender From a Mixed Effects Poisson Model With 
Random Intercepts
Men Women
Model 1
−2 log-likelihood 19,354 31,595
Parameter Estimate 95% CI Estimate 95% CI
Neither condition Reference
Arthritis (LB) 0.08 (−0.02, 0.18) 0.28 (0.20, 0.35)**
CVD 0.18 (0.08, 0.28)** 0.24 (0.15, 0.33)**
Both 0.19 (0.08, 0.30)** 0.44 (0.36, 0.52)**
Time, y 0.07 (0.05, 0.09)** 0.06 (0.05, 0.08)**
Baseline age 0.09 (0.07, 0.10)** 0.07 (0.08, 0.08)**
Time × arthritis 0.03 (0.01, 0.06)* 0.02 (0.01, 0.04)*
Time × CVD 0.06 (0.04, 0.08)** 0.07 (0.05, 0.09)**
Time × both OA and CVD 0.04 (0.02, 0.07)** 0.03 (0.01, 0.05)**
Model 2
−2 log-likelihood 16,970 28,407
Parameter Estimate 95% CI Estimate 95% CI
Neither condition Reference
Arthritis (LB) 0.09 (−0.01, 0.20) 0.28 (0.20, 0.36)**
CVD 0.10 (−0.01, 0.20) 0.23 (0.14, 0.32)**
Both 0.10 (−0.014, 0.21) 0.42 (0.34,0.50)**
Time, y 0.04 (0.02, 0.06)** 0.07 (0.05, 0.08)**
Baseline age 0.07 (0.06, 0.09)** 0.05 (0.04, 0.06)**
Time × arthritis 0.05 (0.02, 0.07)** 0.01 (−0.01, 0.03)
Time × CVD 0.08 (0.06, 0.11)** 0.05 (0.02,0.07)**
Time × both OA and CVD 0.06 (0.03, 0.08)** 0.02 (0.01, 0.04)**
Body mass index 0.03 (0.01, 0.05)** 0.03 (0.02, 0.04)**
Education, y −0.03 (−0.05, −0.01)** −0.03 (−0.04, −0.01)**
Physical activity summary score −0.05 (−0.07, −0.03)** −0.05 (−0.06, −0.04)**
Diabetes 0.72 (0.51, 0.94)** 0.47 (0.34, 0.61)**
Hypertension 0.25 (0.02, 0.48)* 0.29 (0.15, 0.42)**
Any alcohol consumption† NA NA −0.11 (−0.23, 0.02)
Time-dependent 3MSE score −0.01 (−0.01, −0.01)** −0.01 (−0.01, −0.01)**
Notes: CI = confidence interval; CVD = cardiovascular conditions; df = degrees of freedom; IADL = Instrumental Activities of Daily Living; LB = lower body; 
NA = not available; OA = osteoarthritis alone. Men: model 1 versus model 2, chi square = 2,384, df  = 6, p < .0001; women: model 1 versus model 2, chi 
square = 3,188, df = 7, p < .0001. Estimate reflects a 1 unit change in IADL.
*p < .05, **p < .01.
†Not adjusted in models for men since it is not statistically significant.
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